Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice

Surgery

Volumn 126, Issue 2, 1999, Pages 438-442

  Cobb, J Perren ^a,b   Hotchkiss, Richard S ^a,b   Swanson, Paul E ^a,b   Chang, Kathy ^a,b   Qiu, Yuyu ^a,b   Laubach, Victor E ^a,b   Karl, Irene E ^a,b   Buchman, Timothy G ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; METRONIDAZOLE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ABDOMINAL INFECTION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CONTROLLED STUDY; ENZYME DEFICIENCY; EXPERIMENTAL MODEL; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LIGATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

EID: 0032863627     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(99)70189-3     Document Type: Article

References (25)

1. 1. Kilbourn RG, Traber DL, Szabo C. Nitric oxide and shock. Disease-A-Month 1997;43:277-348.
2. ω-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990;172:1132-8.
3. 3. Cobb JP, Cunnion RE, Danner RL. Nitric oxide as a target for therapy in septic shock. Crit Care Med 1993;31:1261-3.
4. 4. Cobb JP, Danner RL. Nitric oxide and septic shock. JAMA 1996;275:1192-6.
5. 3. Freeman BD, Cobb JP. NOS as a therapeutic target in sepsis: More questions than answers? Crit Care Med 1998;26: 1469-70.
6. 6. Hata JS, Dellinger RP. Nitric oxide inhibition in the treatment of septic shock. Crit Care Med 1995;23:1621-4.
7. 7. Fink MP. Just say no to NO, yes? Crit Care Med 1996;24: 1772-4.
8. 8. Hollenberg SM. Inhibition of nitric oxide synthesis in sepsis: a promising strategy? Crit Care Med 1998;26:638-9.
9. 9. Hollenberg SM. A yellow light for nitric oxide synthase inhibitors in sepsis: proceed with caution. Crit Care Med 1998;26:815-6.
10. 10. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995;81:641-50.
11. 11. Wei X, Charles IG, Smith A, Ure J, Feng G, Huang F, et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995;375:408-11.
12. 12. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A 1995;92:10688-92.
13. 13. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1998;100:2417-23.
14. 14. Heirholzer C, Harbrecht B, Menezes J, Kane J, MacMicking J, Nathan C, et al. Essential role of induced nitric oxide in the initiation of the inflammatory response following hemorrhgic shock. J Exp Med 1998;187:917-28.
15. 15. Parvathaneni LS, Boyle WA, Sauter C, Maher GM, Dunnigan K, Laubach VE, Buchman TG, Cobb JP. iNOS gene deficiency prevents endotoxin-induced catecholamine hyporesponsiveness in murine mesenteric microvessels [abstract]. Assoc Academic Surg 1998;November, 1998.
16. 16. Baker CC, Chaudry IH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a marine cecal ligation and puncture model. Surgery 1983;94:331-5.
17. 17. Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE. Apoptosis in lymphoid and parenchymal cell during sepsis: findings in normal and T & B cell deficient mice. Crit Care Med 1997;25:1298-1307.
18. 18. Hotchkiss RS, Swanson PE, Knudson CM, Chang KC, Cobb JP, Osborne DF, et al, Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 1999;162:4148-56.
19. 19. Hotchkiss RS, Swanson PE, Freeman BD, Tinsely KW, Cobb JP, Matuschak GM, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999;in press.
20. 20. Fehsel K, Kroncke KD, Meyer KL, Huber H, Wahn V, Kolb-Bachofen V: Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 1995;155:2858-65.
21. 21. Sciorati C, Rovere P, Ferrarini M, Heltai S, Manfredi AA, Clementi E. Autocrine nitric oxide modulates CD95-induced apoptosis in gammadelta T lymphocytes. J Biol Chem 1997;272:23211-5.
22. 22. Gover R, Lopez A, Lorente J, et al. Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock [abstract]. Crit Care Med 1999;27(Suppl 1):A33.
23. 23. Cobb JP. Use of nitric oxide synthase inhibitors to treat septic shock: the light has changed from yellow to red. Crit Care Med 1999;in press.
24. 24. Laubach VE, Foley PL, Shockey KS. Tribble CG, Kron IL. Protective roles of nitric oxide and testosterone in endotoxemia: evidence from NOS-2 deficient mice. Am J Physiol 1998;275:H2211-8.
25. 25. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994;78:931-6.